Bloom Tree Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-285,700
Closed -$12.1M 137
2021
Q4
$12.1M Sell
285,700
-1,400
-0.5% -$58.8K 1.62% 18
2021
Q3
$12.5M Buy
287,100
+23,400
+9% +$1.04M 1.48% 23
2021
Q2
$11.3M Sell
263,700
-6,300
-2% -$265K 1.19% 24
2021
Q1
$10.4M Buy
+270,000
New +$10.2M 0.85% 29

Other funds holding BSX

Bloom Tree Partners's BSX Position: Q1 2021 in Review

Bloom Tree Partners sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 1,684,730 shares — an estimated $63.8M sold.

Bloom Tree Partners first reported a position in BSX in Q2 2020 and held it in 3 quarters. The position peaked at $60.6M in Q4 2020. 830 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Bloom Tree Partners reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • Bloom Tree Partners sold 1,684,730 Boston Scientific shares in Q1 2021, an estimated $63.8M.
  • Bloom Tree Partners first reported a position in Boston Scientific in Q2 2020 and held it in 3 quarters.
  • Bloom Tree Partners's Boston Scientific position peaked at $60.6M in Q4 2020.
  • 830 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Bloom Tree Partners's 13F filing for Q1 2021, filed 14 May 2021.